Systemic White Blood Cell Count as a Biomarker Associated with Severity of Chronic Obstructive Lung Disease

Abstract

BackgroundChronic obstructive pulmonary disease (COPD), is a chronic inflammatory disorder. We evaluated whether white blood cell (WBC) count, is associated with the severity of COPD, independent of other inflammatory conditions, such as metabolic syndrome.MethodsThe WBC counts were compared between 1227 COPD patients and 8679 non-COPD adults older than 40. The relationships between the WBC count, lung function, and symptoms score in COPD patients, were determined, using general linear regression analyses.ResultsThe WBC count was negatively associated with forced vital capacity (FVC, L), FVC (% predicted), forced expiry volume in one second (FEV1, L), and FEV1 (% predicted) in COPD patients. Additionally, the WBC count was independently associated with the quality of life measure, by EQ5D-index score. However, this relationship between WBC count, and disease severity, was not significant in current smokers, because of the confounding effect of smoking, on the WBC count.ConclusionThe WBC count is associated with current smoking status and COPD severity, and a risk factor for poor lung function, and quality of life, especially in non-currently smoking COPD patients. The WBC count can be used, as an easily measurable COPD biomarker.

Role of CBC Parameters in COPD with Acute Exacerbation in a Tertiary Care Center

“…Chronic obstructive pulmonary disease (COPD) is a complex and heterogenous disease characterised by chronic inflammation in the airways by noxious particle such as tobacco smoking. 1 Chronic obstructive pulmonary disease is a major global health problem with an upward trend. 2 It is characterised by progressive air flow limitation that is not fully reversible and is associated with an abnormal inflammatory response of the lung to noxious particles or gases.…”

Granulocyte-CSF links destructive inflammation and comorbidities in obstructive lung disease

“…It is surprising, given the important progress in identifying novel gene variants in genome-wide association studies (8,9), that the trait most strongly associated with COPD in large prospective biomarker studies is a simple elevation in peripheral WBC count (10)(11)(12), which is directly linked to severity of lung destruction, propensity for exacerbations, and extent of comorbidities. Thus, we reasoned that probing the molecular basis of WBC regulation and studying the role of hematological CSFs might lead to novel insights into COPD and its comorbidome.…”

Systemic White Blood Cell Count as a Biomarker for Chronic Obstructive Pulmonary Disease: Utility and Limitations

“…In Koo et al's study3, systemic WBC count was higher in more severe COPD patients only in the non-current smoking group. The mechanism was not fully understood yet.…”